Incidence, Treatment Patterns, and Mortality for Patients with Breast Cancer During the First Year of the COVID-19 Pandemic: a Population-based Study

Overview

Journal Breast Cancer Res Treat

Specialty Oncology

Date 2024 Dec 2

PMID 39621161

Authors

Jose Pablo Leone

Julieta Leone

Michael J Hassett

Rachel A Freedman

Jorge Avila

Carlos T Vallejo

Nabihah Tayob

Sara M Tolaney

Nancy U Lin

Affiliations

Soon will be listed here.

Abstract

Purpose: The COVID-19 pandemic created significant disruptions in the diagnosis and treatment of breast cancer (BC). Several public health measures were taken with limited evidence on their potential impact. In this observational study, we sought to compare the incidence of BC, treatment patterns, and mortality during 2020 versus 2018 and 2019.

Methods: Using the Surveillance, Epidemiology, and End Results program, we identified 37,834 patients with ductal carcinoma in situ (DCIS) and 199,594 with invasive BC between 2018 and 2020. We assessed age-adjusted incidence rates of DCIS and invasive BC as cases per 100,000, treatment patterns, and mortality in 2020 versus 2018 and 2019.

Results: From 2019 to 2020, the incidence of female DCIS decreased from 36.4 to 31.0, and the incidence of female invasive BC decreased from 184.2 to 166.6. Among females, the relative reductions in incidence from 2019 to 2020 were 14.8% for DCIS, 12.1% for stage I, 5.8% for stage II, 2.6% for stage III, and 1.9% for stage IV. Comparing 2020 to 2018-2019 in invasive BC, we observed significant changes in treatment patterns with decreased use of surgery or radiation and increased use of chemotherapy. The 12-month mortality rates were 4.49%, 4.37%, and 4.57% for 2018, 2019 and 2020, respectively. In the Cox model, there were no significant differences in mortality between patients diagnosed in 2020 versus 2018 or 2019.

Conclusions: During 2020, the incidence of BC decreased significantly. There were reductions in surgery and radiation use, but not in chemotherapy. Although vaccines were largely unavailable and COVID-19 treatments were in development, we saw no differences in 12-month mortality in 2020 versus prior years. The impact on BC-specific outcomes requires further follow-up.

References

Yin K, Singh P, Drohan B, Hughes K . Breast imaging, breast surgery, and cancer genetics in the age of COVID-19. Cancer. 2020; 126(20):4466-4472. PMC: 7436610. DOI: 10.1002/cncr.33113. View

Patt D, Gordan L, Diaz M, Okon T, Grady L, Harmison M . Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors. JCO Clin Cancer Inform. 2020; 4:1059-1071. PMC: 7713534. DOI: 10.1200/CCI.20.00134. View

Bakouny Z, Paciotti M, Schmidt A, Lipsitz S, Choueiri T, Trinh Q . Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic. JAMA Oncol. 2021; 7(3):458-460. PMC: 7809614. DOI: 10.1001/jamaoncol.2020.7600. View

Chen R, Haynes K, Du S, Barron J, Katz A . Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic. JAMA Oncol. 2021; 7(6):878-884. PMC: 8085759. DOI: 10.1001/jamaoncol.2021.0884. View

Nyante S, Benefield T, Kuzmiak C, Earnhardt K, Pritchard M, Henderson L . Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures. Cancer. 2021; 127(12):2111-2121. PMC: 8013451. DOI: 10.1002/cncr.33460. View

Sprague B, Lowry K, Miglioretti D, Alsheik N, Bowles E, Tosteson A . Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic. J Natl Cancer Inst. 2021; 113(9):1161-1167. PMC: 8083761. DOI: 10.1093/jnci/djab045. View

Rocha A, Freitas-Junior R, Ferreira G, Rodrigues D, Sousa Rahal R . COVID-19 and Breast Cancer in Brazil. Int J Public Health. 2023; 68:1605485. PMC: 10020228. DOI: 10.3389/ijph.2023.1605485. View

Bartlett D, Howe J, Chang G, Crago A, Hogg M, Karakousis G . Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations. Ann Surg Oncol. 2020; 27(6):1717-1720. PMC: 7141488. DOI: 10.1245/s10434-020-08461-2. View

Dietz J, Moran M, Isakoff S, Kurtzman S, Willey S, Burstein H . Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020; 181(3):487-497. PMC: 7181102. DOI: 10.1007/s10549-020-05644-z. View

10.

Caswell-Jin J, Shafaee M, Xiao L, Liu M, John E, Bondy M . Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population. Breast Cancer Res Treat. 2022; 194(2):475-482. PMC: 9140322. DOI: 10.1007/s10549-022-06634-z. View

11.

Eijkelboom A, de Munck L, Vrancken Peeters M, Broeders M, Strobbe L, Bos M . Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study. J Hematol Oncol. 2021; 14(1):64. PMC: 8052935. DOI: 10.1186/s13045-021-01073-7. View

12.

Ilgun A, Ozmen V . The Impact of the COVID-19 Pandemic on Breast Cancer Patients. Eur J Breast Health. 2022; 18(1):85-90. PMC: 8734528. DOI: 10.4274/ejbh.galenos.2021.2021-11-5. View

13.

Soran A, Gimbel M, Diego E . Breast Cancer Diagnosis, Treatment and Follow-Up During COVID-19 Pandemic. Eur J Breast Health. 2020; 16(2):86-88. PMC: 7138353. DOI: 10.5152/ejbh.2020.240320. View

14.

Al-Shamsi H, Alhazzani W, Alhuraiji A, Coomes E, Chemaly R, Almuhanna M . A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020; 25(6):e936-e945. PMC: 7288661. DOI: 10.1634/theoncologist.2020-0213. View

15.

Zarzaur B, Stahl C, Greenberg J, Savage S, Minter R . Blueprint for Restructuring a Department of Surgery in Concert With the Health Care System During a Pandemic: The University of Wisconsin Experience. JAMA Surg. 2020; 155(7):628-635. DOI: 10.1001/jamasurg.2020.1386. View

16.

Ribeiro R, Wainstein A, Ribeiro H, Pinheiro R, Oliveira A . Perioperative Cancer Care in the Context of Limited Resources during the COVID-19 Pandemic: Brazilian Society of Surgical Oncology Recommendations. Ann Surg Oncol. 2020; 28(3):1289-1297. PMC: 7519702. DOI: 10.1245/s10434-020-09098-x. View

17.

Poggio F, Tagliamento M, Di Maio M, Martelli V, De Maria A, Barisione E . Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities. JCO Oncol Pract. 2020; 16(11):e1304-e1314. DOI: 10.1200/OP.20.00297. View

18.

Giaquinto A, Sung H, Miller K, Kramer J, Newman L, Minihan A . Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022; 72(6):524-541. DOI: 10.3322/caac.21754. View

19.

Eijkelboom A, de Munck L, Larsen M, Bijlsma M, Tjan-Heijnen V, van Gils C . Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study. Cancer Epidemiol. 2023; 87:102481. DOI: 10.1016/j.canep.2023.102481. View

20.

Gathani T, Dodwell D, Horgan K . The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England. Br J Cancer. 2022; 128(3):481-483. PMC: 9660015. DOI: 10.1038/s41416-022-02054-4. View